Myocardial injury – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:10:24 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Myocardial injury – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Glutathione and Sodium Chloride for Preventing Heart Injury in Pneumonia Patients https://clinicaltrials.eu/trial/study-on-glutathione-and-sodium-chloride-for-preventing-heart-injury-in-pneumonia-patients/ Wed, 29 Apr 2026 14:56:53 +0000 https://clinicaltrials.eu/trial/study-on-glutathione-and-sodium-chloride-for-preventing-heart-injury-in-pneumonia-patients/ This clinical trial is focused on studying the prevention of myocardial injury, which is a type of heart damage, in patients who have pneumonia. The study will use a treatment called TAD® 600 mg/4 ml solution for injection, which contains the active substance glutathione. Glutathione is a chemical that may help protect the heart from damage. The trial will also involve the use of sodium chloride solution, which is commonly used in medical settings as a solvent or diluting agent.

The purpose of the study is to evaluate the effectiveness and safety of TAD® as an additional treatment to prevent heart damage in patients hospitalized with pneumonia. Participants in the study will receive the treatment intravenously, meaning it will be administered directly into a vein. The study will compare the effects of TAD® with those of a placebo to determine its potential benefits. The trial will be conducted over a period of several days, during which participants will be closely monitored for any changes in their heart health.

Throughout the study, various health assessments will be conducted to monitor the participants’ heart function and overall well-being. These assessments will include measuring levels of certain proteins in the blood that indicate heart health, as well as performing tests like electrocardiograms (ECGs) to check heart rhythm and function. The study aims to provide valuable information on whether TAD® can be a safe and effective option for preventing heart damage in patients with pneumonia.

]]>